Exploring the Relationship of SARS-CoV-2 and Uric Acid Levels With a Focus on Gout Patients: A Scoping Review.
gout
gout disease
rheumatic disorder
sars-cov-2
sars-cov-2 (severe acute respiratory syndrome coronavirus -2)
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Mar 2024
Mar 2024
Historique:
received:
16
01
2024
accepted:
27
03
2024
medline:
30
4
2024
pubmed:
30
4
2024
entrez:
30
4
2024
Statut:
epublish
Résumé
Rheumatic diseases are a group of conditions including arthritis and various other conditions that can lead to chronic inflammation within the musculoskeletal system, which can have negative effects on soft tissues, bones, muscles, joints, and connective tissue. One form of arthritis is gout, which is an inflammatory condition in which urate acid crystals build up in joints. Gout is associated with joint swelling, pain, redness, and joint mobility issues. Early diagnosis and treatment are essential to prevent joint degradation and other adverse complications. The condition has been shown to increase the incidence of diseases outside the musculoskeletal system, including the renal and cardiovascular systems. Comorbid conditions associated with gout include but are not limited to type 2 diabetes mellitus (T2DM), hypertension, hyperlipidemia, chronic kidney disease, cardiovascular disease, and heart failure. This systematic review aims to provide insight into the relationship between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, uric acid levels, and gout.
Identifiants
pubmed: 38686242
doi: 10.7759/cureus.57138
pmc: PMC11057641
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e57138Informations de copyright
Copyright © 2024, Patel et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
BMC Endocr Disord. 2021 May 8;21(1):97
pubmed: 33964922
Crit Care. 2021 Jun 14;25(1):212
pubmed: 34127048
J Adv Res. 2017 Sep;8(5):495-511
pubmed: 28748116
ACR Open Rheumatol. 2021 May;3(5):333-340
pubmed: 33856739
Clin Rheumatol. 2022 Jun;41(6):1899-1910
pubmed: 35171364
Pak J Med Sci. 2022 Nov-Dec;38(8):2246-2252
pubmed: 36415243
Lancet Rheumatol. 2022 Apr;4(4):e274-e281
pubmed: 35128470
Clin Rheumatol. 2022 Mar;41(3):811-818
pubmed: 34822044
Clin Med Res. 2023 Jun;21(2):87-94
pubmed: 37407218
Lancet Rheumatol. 2023 Oct;5(10):e622-e632
pubmed: 38251486
ACR Open Rheumatol. 2022 Nov;4(11):948-953
pubmed: 36000538
Int J Infect Dis. 2022 Sep;122:747-754
pubmed: 35811077
Ann Rheum Dis. 2020 Dec;79(12):1544-1549
pubmed: 32796045
Ir J Med Sci. 2023 Oct;192(5):2495-2500
pubmed: 36622628
Arthritis Rheumatol. 2023 Jan;75(1):122-132
pubmed: 36082457
Rheumatology (Oxford). 2013 Jan;52(1):118-26
pubmed: 22989425
Korean J Intern Med. 2023 Mar;38(2):248-253
pubmed: 36646989
Arthritis Rheumatol. 2020 Nov;72(11):1916-1927
pubmed: 32755051
Front Endocrinol (Lausanne). 2021 May 06;12:633767
pubmed: 34025575
Lancet Reg Health West Pac. 2023 Jul 18;38:100843
pubmed: 37520279
Clin Case Rep. 2020 Nov 25;9(1):461-464
pubmed: 33362925